Daniel H Schneiderman Pasithea Therapeutics Corp. (KTTA) insider trading activity

Daniel H Schneiderman is Chief Financial Officer of Pasithea Therapeutics Corp.. Currently has a direct ownership of 26,667 shares of KTTA, which is worth approximately $19,200. The most recent transaction as insider was on Nov 28, 2025, when has been sold 26,667 shares (Common Stock) at a price of $0.75 per share, resulting in proceeds of $20,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.7K

n/a 3M change

n/a 12M change

Total Value Held $19,200

Daniel H Schneiderman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 28 2025	BUY Grant, award, or other acquisition	$20,000 $0.75 p/Share	26,667 Added 50.0%	26,667 Common Stock

Also insider at

FWBI

First Wave BioPharma, Inc. Healthcare

CHIEF FINANCIAL OFFICER

DHS